Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs CAPR✓SelectedUSD · CAPRGSK vs CAPR performance historyLatest closeAs of-1.34%11/18
Stock and ETF performance explorer

GSK vs CAPR

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+102.1%
CAPR return
-74.1%
Excess return
+176.2%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioCAPRExcessAlpha
1D-1.3%-4.5%+3.2%-1.3%
7D-3.1%-28.4%+25.3%-2.9%
30D-0.9%+20.8%-21.6%-1.1%
3M-4.2%+13.4%-17.6%-4.4%
6M-1.6%-71.3%+69.8%-1.3%
YTD+2.6%-72.2%+74.8%+2.9%
1Y+6.2%+42.4%-36.2%+3.5%
3Y+55.0%+164.1%-109.2%+49.3%
5Y+42.8%+149.4%-106.5%+37.2%
10Y+102.1%-74.5%+176.6%+87.3%
All+102.1%-74.1%+176.2%+87.3%

Cumulative growth

Daily Returns

Daily percentage return beside CAPR.

Daily Out/Under-Performance

Portfolio return minus CAPR return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × CAPR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded CAPR wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling